EMA accepts LEO Pharma’s MAA for delgocitinib cream in chronic hand eczema
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment